TITLE

Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease

AUTHOR(S)
Kakuta, Y.; Kinouchi, Y.; Negoro, K.; Takahashi, S.; Shimosegawa, T.
PUB. DATE
October 2006
SOURCE
Gut;Oct2006, Vol. 55 Issue 10, p1527
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
The article presents a letter entitled "Association study of TNFSF 15 polymorphisms in Japanese patients with inflammatory bowel disease," by Y. Kakuta, Y. Kinouchi and K. Negoro published within the issue. The study focuses on the role of tumor necrosis factor superfamily 15 in patients with inflammatory bowel disease.
ACCESSION #
22659611

 

Related Articles

  • BIOLOGICS IN INFLAMMATORY BOWEL DISEASE: HOW MUCH PROGRESS HAVE WE MADE? Sandborn, W. J.; Faubion, W. A. // Gut;Sep2004, Vol. 53 Issue 9, p1366 

    The article focuses on the progress made in the treatment of inflammatory bowel disease with biologic therapies, concentrating primarily on the tumor necrosis factor (TNF) inhibitors infliximab, etanercept, adalirnumab, CDP87O, CDP571 and onercept, and on the selective adhesion molecule...

  • The Month of Birth is Linked to the Risk of Crohn's Disease in the Israeli Population. Chowers, Yehuda; Odes, Shmuel; Bujanover, Yoram; Eliakim, Rami; Bar Meir, Simon; Avidan, Benjamin // American Journal of Gastroenterology;Oct2004, Vol. 99 Issue 10, p1974 

    OBJECTIVE: The main objective is to study whether the month of birth is associated with the development of Crohn's disease (CD) in the Israeli Jewish population.BACKGROUND: It was suggested that perinatal exposure to infectious agents may have a role in the pathogenesis of CD. Due to the...

  • CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease. Alexander Rodgers; Adrian Cummins // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2063 

    Abstract  The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn’s...

  • CARD15 Genotype-Phenotype Relationships in a Small Inflammatory Bowel Disease Population with Severe Disease Affection Status. Nigel Crawford; Daniel Colliver; M. Eichenberger; Alisa Funke; Valentina Kolodko; Gary Cobbs; Robert Petras // Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2716 

    Abstract  Inflammatory bowel disease (IBD; MIM# 266600) is subdivided on the basis of clinical findings as either Crohn’s disease (CD), ulcerative colitis (UC), or indeterminate colitis (IC). Three previously described mutations within the IBD susceptibility gene...

  • The prevalence and outcome of jejunal lesions visualized by small bowel endoscopy in Crohn's disease. Balzola, Federico; Cullen, Garret; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2013, Vol. 14 Issue 1, p26 

    The article presents a study that determines the prevalence and outcome of jejunal lesions in patients with Crohn's disease. It describes the method of the study that uses small bowel capsule endoscopy for accurate visualization of lesions on the mucosal surface. It notes the result of the study...

  • An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis. Kang, Silvia S; Bloom, Seth M; Norian, Lyse A; Geske, Michael J; Flavell, Richard A; Stappenbeck, Thaddeus S; Allen, Paul M // PLoS Medicine;Mar2008, Vol. 5 Issue 3, pe41 

    Paul Allen and colleagues describe the development of a mouse model of fulminant ulcerative colitis with multiple genetic hits in immune regulation which can be moderated by anti-cytokine therapy and broad-spectrum antibiotics.

  • FUNCTIONAL SYMPTOMS IN INFLAMMATORY BOWEL DISEASE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA99 

    Functional symptoms seem common in inflammatory bowel disease (IBD), putting patients at risk of mismanagement. There is little existing literature, but one study suggested a prevalence of 33% in ulcerative colitis and 57% in Crohn's disease, higher than that in the general population. The...

  • Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Thomas, Saskia; Baumgart, Daniel // Inflammopharmacology;Feb2012, Vol. 20 Issue 1, p1 

    Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent...

  • The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity. Clara, Ian; Lix, Lisa M.; Walker, John R.; Graff, Lesley A.; Miller, Norine; Rogala, Linda; Rawsthorne, Patricia; Bernstein, Charles N. // American Journal of Gastroenterology;Jul2009, Vol. 104 Issue 7, p1754 

    OBJECTIVES:A single-item indicator of disease activity over an extended period of time, the Manitoba Inflammatory Bowel Disease Index (MIBDI), is introduced and compared against several standard measures for assessing activity in patients with Crohn's disease (CD) and ulcerative colitis...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics